This study is in progress, not accepting new patients
X-linked Hypophosphatemia Disease Monitoring Program
Summary
- Location
- at UCLA UCSF
- Dates
- study startedcompletion around
- Principal Investigator
- by Anthony Portale (ucsf)
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Anthony Portale (ucsf)
Professor, Pediatrics, School of Medicine. Authored (or co-authored) 100 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Ultragenyx Pharmaceutical Inc
- ID
- NCT03651505
- Study Type
- Observational
- Participants
- About 780 people participating
- Last Updated